Biotrend Cevre Ve Stock Fundamentals
| BIOEN Stock | TRY 17.85 0.15 0.85% |
Biotrend Cevre ve fundamentals help investors to digest information that contributes to Biotrend Cevre's financial success or failures. It also enables traders to predict the movement of Biotrend Stock. The fundamental analysis module provides a way to measure Biotrend Cevre's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotrend Cevre stock.
Biotrend |
Biotrend Cevre ve Company Operating Margin Analysis
Biotrend Cevre's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biotrend Cevre Operating Margin | 0.22 % |
Most of Biotrend Cevre's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotrend Cevre ve is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Biotrend Cevre ve has an Operating Margin of 0.2216%. This is 98.89% lower than that of the Utilities sector and significantly higher than that of the Utilities—Renewable industry. The operating margin for all Turkey stocks is 104.02% lower than that of the firm.
Biotrend Cevre ve Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotrend Cevre's current stock value. Our valuation model uses many indicators to compare Biotrend Cevre value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotrend Cevre competition to find correlations between indicators driving Biotrend Cevre's intrinsic value. More Info.Biotrend Cevre ve is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.67 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biotrend Cevre ve is roughly 1.49 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biotrend Cevre by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biotrend Cevre's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biotrend Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotrend Cevre's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotrend Cevre could also be used in its relative valuation, which is a method of valuing Biotrend Cevre by comparing valuation metrics of similar companies.Biotrend Cevre is currently under evaluation in operating margin category among its peers.
Biotrend Fundamentals
| Return On Equity | 0.0978 | |||
| Return On Asset | 0.0657 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.22 % | |||
| Shares Owned By Insiders | 67.23 % | |||
| Shares Owned By Institutions | 1.80 % | |||
| Price To Earning | 114.34 X | |||
| Revenue | 427.7 M | |||
| Gross Profit | 123.34 M | |||
| EBITDA | 84.88 M | |||
| Net Income | 3.79 M | |||
| Cash And Equivalents | 25.91 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 696.56 M | |||
| Debt To Equity | 2.09 % | |||
| Current Ratio | 0.77 X | |||
| Book Value Per Share | 0.98 X | |||
| Cash Flow From Operations | (326.18 M) | |||
| Earnings Per Share | 0.01 X | |||
| Target Price | 13.1 | |||
| Number Of Employees | 529 | |||
| Total Asset | 1.83 B | |||
| Net Asset | 1.83 B |
About Biotrend Cevre Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotrend Cevre ve's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotrend Cevre using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotrend Cevre ve based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Biotrend Cevre Ve Enerji Yatirimlari Anonim Sirketi engages in the solid waste management and energy production activities in Turkey. The company was founded in 2017 and is based in Istanbul, Turkey. BIOTREND CEVRE is traded on Istanbul Stock Exchange in Turkey.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biotrend Stock
Biotrend Cevre financial ratios help investors to determine whether Biotrend Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotrend with respect to the benefits of owning Biotrend Cevre security.